FGFR2 mutations promote endometrial cancer progression through dual engagement of EGFR and Notch signalling pathways
Abstract Background Mutations in the receptor tyrosine kinase gene fibroblast growth factor receptor 2 (FGFR2) occur at a high frequency in endometrial cancer (EC) and have been linked to advanced and recurrent disease. However, little is known about how these mutations drive carcinogenesis. Methods...
Kaydedildi:
| Asıl Yazarlar: | , , , , , , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Wiley
2023-05-01
|
| Seri Bilgileri: | Clinical and Translational Medicine |
| Konular: | |
| Online Erişim: | https://doi.org/10.1002/ctm2.1223 |
| Etiketler: |
Etiket eklenmemiş, İlk siz ekleyin!
|